86 results
Page 3 of 5
6-K
EX-99.1
tml318nkkl9k2yyb6mt1
3 Nov 20
Current report (foreign)
6:00am
6-K
EX-99.1
xx4n22uu 7noj8xju
13 Oct 20
Current report (foreign)
6:15am
6-K
EX-99.1
rvhlq9 rxx8kpeh7
28 Sep 20
Current report (foreign)
6:00am
6-K
EX-99.2
032xlu
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
1us7nw3 yl4u2tqz4
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.1
u65u9575u
4 Jun 20
Current report (foreign)
11:01am
6-K
EX-99.1
b0sv878e
26 May 20
Gilead and Galapagos Announce Positive Topline Results of Phase 2B/3 Trial of Filgotinib In Moderately to Severely Active Ulcerative Colitis
6:10am
6-K
EX-99.2
6nr0b0vp eeqqy
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
tnfzdjz016yh e6c
9 Dec 19
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
10:11am
6-K
EX-99.1
wq3gsqq 5o
12 Nov 19
Current report (foreign)
6:15am
6-K
EX-99.2
llk pask7
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.1
rm4brfiv907934us1
11 Oct 19
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks In Finch 1 and Finch 3 Studies In Rheumatoid Arthritis
6:00am
6-K
EX-99.3
0d2q7103
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.2
3fiv5
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99
nusp451
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.1
2hz7 fw2j6cspqi
11 Jun 19
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
6:05am
6-K
EX-99.2
0hlj8746t8 zh7j8
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm